ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Eyetech Pharmaceuticals


Include trials that are no longer recruiting patients.

5 studies were found.
1.RecruitingIntravitreous Pegaptanib Sodium Injection in patients with Exudative Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
2.RecruitingPegaptanib Sodium Compared to Sham Injection in Patients with Recent Vision Loss due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
Condition: Macular Degeneration
3.RecruitingPegaptanib Sodium on Foveal Thickening in Patients with Exudative Subfoveal Age-related Macular Degeneration (AMD)
Condition: Macular Degeneration
4.No longer recruitingPhase II Study of anti-VEGF in Diabetic Macular Edema
Condition: Diabetic Macular Edema
5.CompletedPhase II/III study of anti-VEGF in neovascular AMD
Conditions: Macular Degeneration; Choroidal Neovascularization

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act